News & Updates

Show Multimedia Only

Is EBRT after Y-90 safe for HCC patients?

External beam radiation therapy (EBRT) after Yttrium-90 radioembolization (Y-90) does not appear to worsen hepatoxicity or inferior oncologic outcomes in patients with hepatocellular carcinoma (HCC) when compared with EBRT alone, a study has shown.

Is EBRT after Y-90 safe for HCC patients?

8 hours ago

Cabozantinib plus nivolumab, ipilimumab improves PFS in advanced renal cell carcinoma

9 hours ago by

Adding cabozantinib to nivolumab and ipilimumab as first-line therapy, compared with placebo, results in prolonged progression-free survival (PFS) among untreated patients with advanced renal cell carcinoma (RCC), with no new safety signals seen, as shown by the results of the phase III COSMIC-313 study.

Cabozantinib plus nivolumab, ipilimumab improves PFS in advanced renal cell carcinoma

9 hours ago

FOLFIRI-ramucirumab shows promise as second-line therapy in advanced UGI cancers

10 hours ago

Combination therapy with FOLFIRI-ramucirumab exhibits survival advantage similar to ramucirumab plus paclitaxel in patients with advanced upper gastrointestinal (UGI) cancers, reveals a study. However, FOLFIRI-ramucirumab is associated with a longer real-world time to treatment discontinuation (rwTTD).

FOLFIRI-ramucirumab shows promise as second-line therapy in advanced UGI cancers

10 hours ago

Physical activity intensity matters more for chronic disease prevention

11 hours ago by

Prioritizing physical activity (PA) intensity over volume may yield greater benefits for preventing most noncommunicable diseases (NCDs), a prospective study suggests.

Physical activity intensity matters more for chronic disease prevention

11 hours ago

Bempedoic acid beneficial in Asians with inadequately controlled hypercholesterolemia

15 hours ago

Treatment with bempedoic acid helps lower low‐density lipoprotein cholesterol (LDL‐C) levels in Asian patients who have LDL-C elevations despite receiving lipid-lowering therapy, including statins, according to a study from Taiwan.

Bempedoic acid beneficial in Asians with inadequately controlled hypercholesterolemia

15 hours ago

Sustained adherence to growth hormone therapy boosts growth outcomes in children

a day ago

Children maintaining a sustained adherence rate of at least 85 percent to daily growth hormone therapy see a clinically meaningful improvement in growth over 2 years, as shown in a retrospective study.

Sustained adherence to growth hormone therapy boosts growth outcomes in children

a day ago

One in eight young men in SG has dyslipidaemia

a day ago by

Dyslipidaemia appears to be prevalent among adolescents and young men in Singapore, including those without traditional metabolic risk factors, according to local research.

One in eight young men in SG has dyslipidaemia

a day ago

Immunotherapy modestly improves response rates in HR+ breast cancer

a day ago

Patients with HR+/HER2‒ breast cancer treated with immunotherapy show modest improvements in complete response rates, reports a study.

Immunotherapy modestly improves response rates in HR+ breast cancer

a day ago

$Do calcium, vitamin D supplements prevent fractures, falls?$

Do calcium, vitamin D supplements prevent fractures, falls?

a day ago by

The use of calcium, vitamin D, or combined supplementation does not appear helpful in preventing fractures and falls, claims a study.

Do calcium, vitamin D supplements prevent fractures, falls?

a day ago

Clipping before ECI lowers risk of ectopic embolisms in gastric varices

a day ago

Adding clip prior to endoscopic cyanoacrylate injection (ECI) helps prevent ectopic embolism in patients with fundal varices with a portal-systemic shunt, without compromising safety or efficacy, as shown in a recent study.

Clipping before ECI lowers risk of ectopic embolisms in gastric varices

a day ago

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Is EBRT after Y-90 safe for HCC patients?

Is EBRT after Y-90 safe for HCC patients?

Cabozantinib plus nivolumab, ipilimumab improves PFS in advanced renal cell carcinoma

Cabozantinib plus nivolumab, ipilimumab improves PFS in advanced renal cell carcinoma

FOLFIRI-ramucirumab shows promise as second-line therapy in advanced UGI cancers

FOLFIRI-ramucirumab shows promise as second-line therapy in advanced UGI cancers

Physical activity intensity matters more for chronic disease prevention

Physical activity intensity matters more for chronic disease prevention

Bempedoic acid beneficial in Asians with inadequately controlled hypercholesterolemia

Bempedoic acid beneficial in Asians with inadequately controlled hypercholesterolemia

Sustained adherence to growth hormone therapy boosts growth outcomes in children

Sustained adherence to growth hormone therapy boosts growth outcomes in children

One in eight young men in SG has dyslipidaemia

One in eight young men in SG has dyslipidaemia

Immunotherapy modestly improves response rates in HR+ breast cancer

Immunotherapy modestly improves response rates in HR+ breast cancer

Do calcium, vitamin D supplements prevent fractures, falls?

Do calcium, vitamin D supplements prevent fractures, falls?

Clipping before ECI lowers risk of ectopic embolisms in gastric varices

Clipping before ECI lowers risk of ectopic embolisms in gastric varices